This is big people , Suncor is the ringer

New Post Public Reply Private Reply Replies (0) Message Board
farml1234
263
This is big people , Suncor is the ringer .




Dragonsmyth7 (26)

User Actions




October 27, 2019 - 12:16 PM92 Reads
Post# 30274127


Hey, it worked. Ucore made me rich, now what?

Good Morning, Everybody
The marine air/fog is thick this morning up here in the Seattle area. But it looks like it will be a great Fall day. The cats have been fed and are off to clean and nap. The wife is a sleep and I am on my first cup of coffee. If the grand kid is not working today, I am off to help him setup his Roth IRA. I have not setup an account in so long they changed a bunch of things. So we are working ours way through it .
Okay, lets get of Sherlock Home caps on and think about where Ucore is going. Yes, I have the hat. The kids had to endure Sherlock Homes movies and TV shows growing up and me asking Homes type questions. For my Birthday one year I got a Home kit. A wood box with a hat, mag glass, a pipe, and a mini violin. The top was engrage with "Open for 4 pipe problems".

Lets look at Ucore, this is a company that does not do things by the seat of there pants. They build a step by step plan and then work to do the plan. They have stated the plan.
They marketed MRT and lined up deals.
Buy IBC to get the IP on MRT.
After buying IBC, They will have income from IBC contracts
They have two US Senators pushing DOD to use Ucore/MRT, So most likely they will get USG money.
So most likely in the first quarter of 2020 Ucore will be at a one dollar a share to possiblely ten bucks a share depending on the size of the DOD contract.
The first MRT deal will be with Sunor, they have a plant to plug the MRT into. As Jim said the low hanging friut.
After Ucore is above 4 dollars a share for six months they can get listed on the NASDAQ. This take them off the OTC board and hopefully out of hands of people shorting the stock. This also allows the big boys to buy in direct to Ucore.
It should take no longer than six months to build the MRT part of Suncor plant in the oil sands. So income from than in the last quarter of 2020 to Ucore. At a guess 5 dollars a barrel added valve with Ucore getting one dollar per barrel, one million barrel per day. So Ucore profit would be one million dollars per day with a stock price of fifty to one hundred per share.
At some point Ucore is going to start spinning off spoke companies and share numbers will start going up with each company.

Said that the average guy on this board has 100K of shares. Hopefully all of those shares are in a Roth IRA or same kind of Canadian account. Yes, spelling was never my strong suit.
At a dollar equals $100,000
At ten equals $1,000,000
At one hundred equals $10,000,000
If you are the average guy you are going nuts at this point. Trouble sleeping, looking at family odd because they know how much is in the account. You start telling people about Ucore, and they start lining up at your door with there hand out trying to sell you the newest greatest thing.

Been there done that, it is not fun.

If you tell people about Ucore, You sold to soon before it took off to the moon. Paid off the mortgage and bills only have a few thousand share. Wish you had rode it up.

Like I said before, have one small block of shares that when Ucore reaches a certain price sell and pay off everything, maybe buy a new car.

It is your account do not let anybody tell you when to sell, You have done the DD and found Ucore, not them.

The plan is get MRT, then Sucor, then SMC and DOD, the spokes Then to the moon. Let all go for a ride
You all have a great day.
Dragon


Read more at https://stockhouse.com/companies/bullboard?sy...bEAfDCY.99

Ucore Rare Metals Inc. (UURAF) Stock Research Links

UURAF Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Leo Cancer Care's Upright Radiotherapy Milestone

Updated Category News Views 4

Upright Radiotherapy: Breaking Tradition in Cancer Care Here's a twist in the world of cancer treatment folks weren't exactly expecting. Leo Cancer Care has flipped the script by taking radiotherapy from a concept to an actual clinical reality with their Upright Platform. Yes, we're talking about standing up while getting treated, and it's not just a gimmick—it's a game...

Continue Reading
Revamping Children's Radiotherapy: Leo Cancer Care's Vision

Updated Category News Views 5

The latest buzz in pediatric radiotherapy is shaking things up, and it’s all thanks to a game-changing shift in how treatment is delivered to kids. We're eyeballing Leo Cancer Care's innovative approach that might just redefine how these young patients face their battles. Standing Tall: A New Chapter in Proton Therapy In June, Stanford Medicine dished out the first...

Continue Reading
Synagro Technologies Faces Lawsuit Over Unpaid Expenses

Updated Category News Views 6

Another Day, Another Lawsuit in Corporate America When it rains, it pours, especially in the corporate world where companies occasionally seem to forget they're playing with other people's livelihoods. Now, it's Synagro Technologies, Inc. facing the music. The company is under fire from Blumenthal Nordrehaug Bhowmik De Blouw LLP, a law firm well-versed in employee rights...

Continue Reading
Melrose Fire Station Reaches Steel Topping Milestone

Updated Category News Views 4

Metal and Milestones: A New Era for Melrose Rolling into Melrose, Massachusetts, there's some serious action kicking off with the new Fire Engine 2 Station reaching a steel topping milestone. This phase isn't just about slapping on another beam; it's the crescendo of diligent teamwork from all the hands involved—from CTA Construction Managers to the clout of Ironworkers...

Continue Reading
Fuse Oncology Showcases New iRT Workflow at ASTRO

Updated Category News Views 4

Revolutionizing Charge Capture in Oncology Fuse Oncology's latest showcase at the ASTRO 2026 Annual Meeting isn't just about flashy presentations—it's looking to change how radiation oncology departments handle complex workflows. If you've ever delved into the maze of oncology billing, you know it's rife with opportunities for errors and inefficiencies. Skip one charge,...

Continue Reading
Salveo Home Care Faces Class Action Over Labor Violations

Updated Category News Views 5

Another Company Lands in Hot Water Alright, it looks like Salveo Home Care is in the spotlight for all the wrong reasons. The home care provider—which should have been minding its P's and Q's—is now facing a class action suit. Why, you ask? Well, for allegedly skimping on wages and dodging legal obligations that leave their employees hanging dry. The Allegations are...

Continue Reading
AI Memory Growth Pushes Limits at GMIF2026 Summit

Updated Category News Views 3

The Memory and Storage Race in the AI Era The 5th GMIF2026 Innovation Summit wrapped up in Shenzhen, and boy, was it a heavyweight bout. You could practically feel the tension in the room as industry giants sparred over the future of memory and storage in AI. This wasn't just another trade show pow-wow; this was a strategic chess match over where AI infrastructure is...

Continue Reading
DKS Facing Class Action Over Stock Slump Allegations

Updated Category News Views 3

A Burst Bubble at DICK'S Sporting Goods Grit your teeth and hang on—DICK'S Sporting Goods has stumbled, and investors are supposed to just weather the storm. From September 8, 2025, through August 24, 2026, if you held DICK'S shares, you've got some explaining to do, or at least you better start reading the fine print. Take note, folks: the deadline to file for lead...

Continue Reading
IASO's FUCASO Shows Robust Results in 2026 Study

Updated Category News Views 7

IASO's Groundbreaking Results Stir Ripples in Oncology Folks, let me paint the picture here with the mighty, nitty-gritty details straight from the heart of China. The 2026 IMS Annual Meeting held a gem that could redefine how investors see the course of hematologic malignancy treatments. IASO Bio dropped some heavy data, showing their fine product, FUCASO, in a...

Continue Reading
Quay Shines in 2026 Prescription Sunglasses Lineup

Updated Category News Views 5

Spotlight on Quay: A Fashion-Forward Prescription Glasses that make you look good and actually correct your vision? That's the holy grail right there. Consumer365 just put Quay front and center in their 2026 rundown of the best prescription sunglasses out there. Let's break this down and see what's got folks buzzing. Diving into Style and Substance Now, if you're like me,...

Continue Reading

Top 5 Most Recently Viewed Articles

Mullen Group Declares Monthly Dividend for Shareholders

Updated Category News Views 112

Mullen Group Ltd. Announces Monthly Dividend Declaration In a significant move for its shareholders, Mullen Group Ltd. has declared a monthly dividend. This exciting news comes as part of the company's ongoing dedication to providing value to its investors. Details of the Dividend The Board of Directors of Mullen Group has announced a monthly dividend of $0.07 per common...

Continue Reading
Bullish Whale Activity Reveals Insights for Quanta Services

Updated Category News Views 109

Understanding Whale Activity in Quanta Services Investors with substantial financial resources have adopted a bullish outlook on Quanta Services (NYSE: PWR). This could serve as an important signal for retail traders to take note of recent developments. What We Found Today Recent patterns in options trading caught our attention. An examination of publicly available...

Continue Reading
Envoy Medical's Innovative Cochlear Implant System Patented

Updated Category News Views 191

Overview of Envoy Medical's Recent European Patent Envoy Medical, Inc. (NASDAQ: COCH), recognized for its focus on cutting-edge hearing systems, has proudly announced the granting of Patent No. 3858425 by the European Patent Office. This patent is a significant milestone for the Company and pertains to their innovative modular cochlear implant system, designed to enhance...

Continue Reading
Compass, Inc. Delivers Historic Financial Performance

Updated Category News Views 108

Compass, Inc. Achieves Record Financial Results Compass, Inc. (NYSE: COMP) recently reported outstanding financial results for the second quarter of 2025, showcasing a remarkable growth trajectory. With year-over-year GAAP net income soaring by 90.3% to a historic $39.4 million, the company demonstrated its robust financial health. This growth is a testament to Compass's...

Continue Reading
Catalyst Bancorp's New Share Buyback Strategy for Growth

Updated Category News Views 162

Catalyst Bancorp, Inc. Unveils New Share Buyback Plan Catalyst Bancorp, Inc. (NASDAQ: CLST), parent company of Catalyst Bank, has recently revealed an exciting new initiative to bolster its shareholder value through a fresh share repurchase plan. This announcement reflects the Company’s commitment to maintaining a strong financial position while actively rewarding its...

Continue Reading